当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 资产负债表

博瑞医药

(688166)

  

流通市值:151.26亿  总市值:151.26亿
流通股本:4.36亿   总股本:4.36亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金1,342,326,203.481,395,350,964.06961,064,394.02606,217,317.45
  应收票据及应收账款399,396,832.51385,078,155.12316,637,331.11328,608,558.32
  其中:应收票据253,3850200,000-
        应收账款399,143,447.51385,078,155.12316,437,331.11328,608,558.32
  应收款项融资4,452,580.983,655,460.1613,377,809.95,495,627.66
  预付款项54,267,558.2779,974,154.4762,200,221.4883,595,346.56
  其他应收款合计2,610,830.873,275,861.49,126,583.595,193,034.5
  存货333,084,521.88358,509,898.72364,252,795.45369,390,282.32
  其他流动资产66,074,167.9780,797,968.561,843,039.3568,097,539.72
  流动资产合计2,202,212,695.962,306,642,462.431,788,502,174.91,466,597,706.53
非流动资产:
  长期应收款7,100,0007,100,0007,100,0004,100,000
  长期股权投资221,091,098.03168,099,990.57122,790,639.35133,689,407
  其他权益工具投资59,015,501.22123,170,901.47113,170,901.4793,763,126.42
  其他非流动金融资产182,209,493.66184,913,698.55133,413,698.5593,666,850.04
  投资性房地产55,242,599.1755,963,221.8556,683,844.5357,404,467.21
  固定资产1,549,999,030.751,517,817,765.221,548,113,4161,486,735,505.63
  在建工程1,203,147,040.561,244,852,534.161,187,202,917.021,237,886,571.45
  使用权资产36,706,169.0539,482,088.3717,026,652.4213,643,586
  无形资产77,590,798.4978,385,899.879,529,289.3686,496,659.93
  开发支出381,097,855.09319,988,650.73302,773,742.35268,149,745.42
  商誉---3,120,100
  长期待摊费用33,721,255.3734,992,085.7736,412,050.4638,422,268.69
  递延所得税资产117,754,440.66111,350,847.8294,679,078.7180,785,460.48
  其他非流动资产378,390,955.65342,291,729.81337,443,273.39295,608,586.5
  非流动资产合计4,303,066,237.74,228,409,414.124,036,339,503.613,893,472,334.77
  资产总计6,505,278,933.666,535,051,876.555,824,841,678.515,360,070,041.3
流动负债:
  短期借款75,042,805.5568,930,180.55110,108,222.21149,265,996.95
  交易性金融负债2,468,149.64,385,847.167,070,265193,138.98
  应付票据及应付账款125,860,815.19144,174,774.54185,894,997.14188,968,432.68
  其中:应付票据-20,000,00019,500,00040,000,000
        应付账款125,860,815.19124,174,774.54166,394,997.14148,968,432.68
  合同负债33,054,337.6731,727,639.3825,559,585.4845,199,400.99
  应付职工薪酬16,201,429.7138,322,952.6956,171,009.5619,693,265.52
  应交税费18,119,736.6317,577,696.9522,225,392.198,204,424.74
  其他应付款合计10,878,878.3212,528,726.738,689,748.6210,164,424
  一年内到期的非流动负债685,030,993.5659,285,010.87845,206,281.51725,461,980.25
  其他流动负债11,604,038.0114,334,91519,380,694.5719,899,756.85
  流动负债合计978,261,184.18991,267,743.871,280,306,196.281,167,050,820.96
非流动负债:
  长期借款1,513,669,8001,574,244,673.67730,488,592.621,008,650,834.39
  应付债券297,874,721.91760,545,457.78657,977,546.33450,128,932.89
  租赁负债22,164,558.0726,003,862.2410,207,868.477,299,521.13
  长期应付款109,978,655.58126,137,703.63142,108,311.17126,019,137.33
  递延收益63,337,679.8865,292,574.967,247,469.9269,202,364.94
  其他非流动负债89,622,641.4589,976,415.0490,330,188.63-
  非流动负债合计2,096,648,056.892,642,200,687.261,698,359,977.141,661,300,790.68
  负债合计3,074,909,241.073,633,468,431.132,978,666,173.422,828,351,611.64
所有者权益(或股东权益):
  实收资本(或股本)435,794,991423,104,454423,103,851423,102,473
  其他权益工具-61,224,231.3561,227,647.7961,234,285.45
  资本公积1,600,722,261.581,076,291,276.041,076,097,485.441,036,377,197.61
  减:库存股20,051,308.6120,051,308.6120,051,308.6110,009,948.64
  其他综合收益-119,902,771.78-85,766,086.11-85,438,838.11-124,695,066.81
  盈余公积102,323,597.2398,567,037.0398,567,037.0386,060,862.59
  未分配利润1,053,439,005.1976,954,615.87967,660,900.48975,972,411.34
  归属于母公司股东权益合计3,052,325,774.522,530,324,219.572,521,166,775.022,448,042,214.54
  少数股东权益378,043,918.07371,259,225.85325,008,730.0783,676,215.12
  股东权益合计3,430,369,692.592,901,583,445.422,846,175,505.092,531,718,429.66
  负债和股东权益合计6,505,278,933.666,535,051,876.555,824,841,678.515,360,070,041.3
公告日期2026-08-312026-04-302026-03-202025-10-31
审计意见(境内)标准无保留意见
TOP↑